Literature DB >> 25148921

Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit.

George Koshy Chiramel1, Shyamkumar Nidugala Keshava, Vinu Moses, Suraj Mammen, Sarada David, Sudipta Sen.   

Abstract

PURPOSE: This manuscript describes the clinical features, imaging findings, treatment details, and short-term outcomes of a series of congenital slow-flow vascular malformations.
METHODS: This was a prospective study of congenital slow-flow vascular malformations involving the orbital region treated at a single institution with percutaneous sclerotherapy.
RESULTS: Ten patients presented during the study period, comprising eight venous malformations, one lymphatic malformation, and one veno-lymphatic malformation. Nine patients underwent percutaneous sclerotherapy under digital subtraction angiography guidance, of which three developed marked rise in intraocular pressure requiring lateral canthotomy. The treatments were performed in the presence of an ophthalmologist who measured the intraorbital pressure during and after the procedure. On follow-up, some of the patients required repeat sessions of sclerotherapy. All patients had improvement of symptoms on follow up after the procedure.
CONCLUSION: Congenital slow-flow vascular malformations of the orbital region are rare lesions that should be treated using a multidisciplinary approach. Monitoring of the intraorbital pressure is required both during and after the procedure to decide about the need for lateral canthotomy to reduce the transiently increased intraorbital pressure.

Entities:  

Mesh:

Year:  2014        PMID: 25148921     DOI: 10.1007/s00270-014-0971-5

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

1.  The Addition of Lipid-Based Contrast Medium does not Inactivate the Detergent Sclerosant Sodium Tetradecyl Sulfate in-vitro.

Authors:  Charlotte L Oliver; Judy Brown; Mike Watkins; Ian McCafferty; Richard J Oliver
Journal:  Cardiovasc Intervent Radiol       Date:  2021-03-11       Impact factor: 2.740

Review 2.  Classification and treatment of orbital venous malformations: an updated review.

Authors:  Tianyuan Li; Renbing Jia; Xianqun Fan
Journal:  Front Med       Date:  2018-08-10       Impact factor: 4.592

3.  Sclerotherapy for eyelid and anterior orbital venous-lymphatic malformation.

Authors:  Mohammad Etezad Razavi; Mohammad Taher Rajabi; Narges Hassanpoor; S Saeed Mohammadi
Journal:  J Curr Ophthalmol       Date:  2019-01-30

4.  Polidocanol monotherapy for a superficial orbital venous malformation in a horse.

Authors:  Tara M Stonex; Ashley E Zibura; Michael Andres; Brian C Gilger; Annie Oh
Journal:  Vet Ophthalmol       Date:  2022-06-01       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.